Who has invested in Inhibikase Therapeutics?

No investors are named on the public record for Inhibikase Therapeutics yet.

Inhibikase Therapeutics Funding: $345M Raised, Growth (2024)

Inhibikase Therapeutics funding overview

Inhibikase Therapeutics is based in Atlanta, Georgia. Inhibikase Therapeutics has raised $345M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Growth announced in May 2024. The round record for Inhibikase Therapeutics runs through 2024; nothing later has been disclosed.

Inhibikase Therapeutics at a glance

Total raised: $345M
Latest round: Growth
Latest round date: May 2024
Headquarters: Atlanta, Georgia

Frequently asked about Inhibikase Therapeutics funding

How much has Inhibikase Therapeutics raised?: Inhibikase Therapeutics has raised $345M in total disclosed funding across the rounds on record.
Who has invested in Inhibikase Therapeutics?: No investors are named on the public record for Inhibikase Therapeutics yet.
What was the latest Inhibikase Therapeutics funding round?: The most recent disclosed round is a Growth, announced in May 2024.
Where is Inhibikase Therapeutics based?: Inhibikase Therapeutics is based in Atlanta, Georgia.
When did Inhibikase Therapeutics last raise?: The last disclosed Inhibikase Therapeutics round closed in May 2024 at Growth.

Inhibikase Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Atlanta below to benchmark round size and investor mix.

Inhibikase Therapeutics Funding: $345M Raised, Growth (2024)

Inhibikase Therapeutics funding overview

Inhibikase Therapeutics at a glance

Frequently asked about Inhibikase Therapeutics funding

Companies related to Inhibikase Therapeutics (18)

Browse related funding lists (3)